Effect of celecoxib on Ca²⁺ handling and viability in human prostate cancer cells (PC3)

References

• Abedinpour, P., Baron, V. T., Welsh, J., Borgström, P. (2011). Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo. Prostate 71:813–823.
   PubMed Web of Science ®Google Scholar
• Basler, J. W., Piazza, G. A. (2004). Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. J Urol 171:S59–S62; discussion, S62–S63.
   Google Scholar
• Berridge, M. J. (2006). Calcium microdomains: organization and function. Cell Calcium 40:405–412.
   PubMed Web of Science ®Google Scholar
• Berridge, M. J. (2008). Smooth muscle cell calcium activation mechanisms. J Physiol 586:5047–5061.
   PubMed Web of Science ®Google Scholar
• Bootman, M. D., Berridge, M. J., Roderick, H. L. (2002). Calcium signalling: more messengers, more channels, more complexity. Curr Biol 12:R563–R565.
   PubMed Web of Science ®Google Scholar
• Bunimov, N., Laneuville, O. (2008). Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis. Cardiovasc Hematol Disord Drug Targets 8:268–277.
   PubMedGoogle Scholar
• Chang, H. C., Cheng, H. H., Huang, C. J., Chen, W. C., Chen, I. S., Liu, S. I. (2006). Safrole-induced Ca2+ mobilization and cytotoxicity in human PC3 prostate cancer cells. J Recept Signal Transduct Res 26:199–212.
   PubMed Web of Science ®Google Scholar
• Chang, H. C., Huang, C. C., Huang, C. J., Cheng, J. S., Liu, S. I., Tsai, J. Y. (2008). Desipramine-induced apoptosis in human PC3 prostate cancer cells: activation of JNK kinase and caspase-3 pathways and a protective role of [Ca2+]i elevation. Toxicology 250:9–14.
   PubMed Web of Science ®Google Scholar
• Clapham, D. E. (1995) Intracellular calcium. Replenishing the stores. Nature 375:634–635.
   PubMed Web of Science ®Google Scholar
• Dahners, L. E., Mullis, B. H. (2004). Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 12:139–143.
   PubMed Web of Science ®Google Scholar
• Das, S., Bhattacharyya, S., Ghosh, S., Majumdar, S. (1999). TNF-alpha induced altered signaling mechanism in human neutrophil. Mol Cell Biochem 197:97–108.
   PubMed Web of Science ®Google Scholar
• Giorgi, C., Romagnoli, A., Pinton, P., Rizzuto, R. (2008). Ca2+ signaling, mitochondria, and cell death. Curr Mol Med 8:119–130.
   PubMed Web of Science ®Google Scholar
• Grynkiewicz, G., Poenie, M., Tsien, R. Y. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450.
   PubMed Web of Science ®Google Scholar
• Hull, M. A. (2005) Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur J Cancer 41:1854–1863.
   PubMed Web of Science ®Google Scholar
• Johnson, A. J., Hsu, A. L., Lin, H. P., Song, X., Chen, C. S. (2002). The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. Biochem J 366:831–837.
   PubMed Web of Science ®Google Scholar
• Kiefer, W., Dannhardt, G. (2004). Novel insights and therapeutical applications in the field of inhibitors of COX-2. Curr Med Chem 11:3147–3161.
   PubMed Web of Science ®Google Scholar
• Lee, K. C., Chang, H. T., Chou, K. J., Tang, K. Y., Wang, J. L., Lo, Y. K. (2001). Mechanism underlying histamine-induced intracellular Ca2+ movement in PC3 human prostate cancer cells. Pharmacol Res 44:547–552.
   PubMed Web of Science ®Google Scholar
• Li, N., Lin, P., Cai, C., Pan, Z., Weisleder, N., Ma, J. (2009). The amino-terminal peptide of Bax perturbs intracellular Ca2+ homeostasis to enhance apoptosis in prostate cancer cells. Am J Physiol Cell Physiol 296:C267–C272.
   PubMedGoogle Scholar
• Liao, J., Schneider, A., Datta, N. S., McCauley, L. K. (2006). Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res 66:9065–9073.
   PubMed Web of Science ®Google Scholar
• Matuszyk, J., Kobzdej, M., Ziolo, E., Kalas, W., Kisielow, P., Strzadala, L. (1998). Thymic lymphomas are resistant to Nur77-mediated apoptosis. Biochem Biophys Res Commun 249:279–282.
   PubMed Web of Science ®Google Scholar
• Merritt, J. E., Jacob, R., Hallam, T. J. (1989). Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 264:1522–1527.
   PubMed Web of Science ®Google Scholar
• Nelson, E. C., Evans, C. P., Mack, P. C., Devere-White, R. W., Lara, P. N., Jr. (2007). Inhibition of Akt pathways in the treatment of prostate cancer. Prostate Cancer Prostatic Dis 10:331–339.
   PubMed Web of Science ®Google Scholar
• Patel, M. I., Subbaramaiah, K., Du, B., Chang, M., Yang, P., Newman, R. A. (2005). Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res 11:1999–2007.
   PubMed Web of Science ®Google Scholar
• Rodan, S. B., Insogna, K. L., Vignery, A. M., Stewart, A. F., Broadus, A. E., D’Souza, S. M. (1983). Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest 72:1511–1515.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., Manola, J., Kaufman, D. S., Oh, W. K., Bubley, G. J., Kantoff, P. W. (2006). Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy. J Clin Oncol 24:2723–2728.
   PubMed Web of Science ®Google Scholar
• Song, X., Lin, H. P., Johnson, A. J., Tseng, P. H., Yang, Y. T., Kulp, S. K., et al. (2002). Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J Natl Cancer Inst 94:585–591.
   PubMed Web of Science ®Google Scholar
• Sooriakumaran, P., Kaba, R. (2005). The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review. Int J Surg 3:278–285.
   PubMedGoogle Scholar
• Sooriakumaran, P., Langley, S. E., Laing, R. W., Coley, H. M. (2007). COX-2 inhibition: a possible role in the management of prostate cancer? J Chemother 19:21–32.
   PubMed Web of Science ®Google Scholar
• Stempak, D., Gammon, J., Klein, J., Koren, G., Baruchel, S. (2002). Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther 72:490–497.
   PubMed Web of Science ®Google Scholar
• Thastrup, O., Cullen, P. J., Drobak, B. K., Hanley, M. R., Dawson, A. P. (1990). Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Aca Sci U S A 87:2466–2470.
   PubMed Web of Science ®Google Scholar
• Thompson, A. K., Mostafapour, S. P., Denlinger, L. C., Bleasdale, J. E., Fisher, S. K. (1991). The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 266:23856–23862.
   PubMed Web of Science ®Google Scholar
• Williams, C. S., Watson, A. J., Sheng, H., Helou, R., Shao, J., DuBois, R. N. (2002). Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res 60:6045–6051.
   Web of Science ®Google Scholar
• Zeng, Y., Lv, X. H., Zeng, S. Q., Tian, S. L., Li, M., Shi, J. (2008). Sustained depolarization-induced propagation of [Ca2+]i oscillations in cultured DRG neurons: the involvement of extracellular ATP and P2Y receptor activation. Brain Res 1239:12–23.
   Google Scholar